One thing people shouldnt do is stop taking Ozempic, Haynes-Ferere says
Where is Sea Buckthorn naturally found
While not yet FDA-approved as a standalone agent, cagrilintide peptide therapy is being investigated for: Obesity treatment Metabolic syndrome management Adjunctive therapy for GLP-1 agonist non-responders Research in combination with emerging agents like retatrutide Note: As of 2025, cagrilintide is still considered a research compound in many jurisdictions
May JM, Mendiratta S, Hill KE, Burk RF
It acts as a senolytic agent in a special way
Triple agonism (GLP-1 + GIP + glucagon) is a real mechanistic advance, not just marketing but the full implications, especially for muscle mass, aren't confirmed yet